NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1932212263 MD
Verify on CMS → Celeste Hart, MD
Endocrinology, Diabetes & Metabolism Physician in Tallahassee, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 298 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
42%
generic claims · 53% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$102.44
4 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Celeste Hart, MD carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 1,612 Medicare Part D claims in 2023.
- 75/100
- CMS neutral score · not measured
- 2K
- Part D claims, 2023
- 42%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1932212263 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1932212263
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-NEUTRAL 75/100
- RX-MID 1,612
- BOOK-LIGHT 519 in Florida
- PHOTO-ENUM Alan Krasner · 2006
Celeste Hart, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,612 ≥ 82nd percentile 82% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Celeste Hart, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Celeste Hart, MD?
CMS neutral score, not measuredPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
1,612 39% vs specialty avg
MIPS final score
75/100
Specialty distribution in Florida
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1932212263 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 08/17/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Celeste Hart, MD. Source: openpaymentsdata.cms.gov.
Total received
$102
Largest payer
BETA BIONICS, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Celeste Hart, MD. To verify Celeste Hart, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Celeste Hart, MD - brand share 53.0%
Endocrinology, Diabetes & Metabolism Physician average
53% brand-name claims vs 42% generic, on 1,612 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,612
Total Claims
$784K
Total Drug Cost
298
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,761
- Total Day Supply
- 111,566
- Brand vs Generic
- 53% brand / 42% generic
- Brand Drug Cost
- $740K
- Generic Drug Cost
- $29K
Patient Demographics
- Average Patient Age
- 72.9 years
- Avg HCC Risk Score
- 1.38
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 23, 65-74: 158, 75-84: 99, 85+: 18
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Celeste Hart, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
220 claims
- Synthroid
Synthroid
136 claims
- Ozempic
Ozempic
134 claims
- Metformin Hcl 74
Metformin Hcl
74 claims
- Trulicity 65
Trulicity
65 claims
- Atorvastatin Calcium 60
Atorvastatin Calcium
60 claims
- Methimazole 56
Methimazole
56 claims
- Glimepiride 50
Glimepiride
50 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 220 |
| Synthroid Levothyroxine Sodium | 136 |
| Ozempic Semaglutide | 134 |
| Metformin Hcl | 74 |
| Trulicity Dulaglutide | 65 |
| Atorvastatin Calcium | 60 |
| Methimazole | 56 |
| Glimepiride | 50 |
| Tresiba Flextouch U-100 Insulin Degludec | 41 |
| Humalog Kwikpen U-100 Insulin Lispro | 40 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in FL →
All providers in Florida →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Celeste Hart, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Celeste Hart, MD's 1,612 claims are below the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Hart, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Hart.
One of 519 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Florida, 5 are shown here.
Dr. Ejigayehu Abate
MD
Jacksonville, FL
Dr. Susan Abend
M.D.
Sarasota, FL
Dr. Daisy Acevedo Morales
MD
South Miami, FL
Dr. Brenda Acosta Ashby
MD
Doral, FL
Dr. Adriane Adami
APRN
Panama City, FL
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Celeste Hart, MD's specialty? ▼
Celeste Hart, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Tallahassee, Florida. Credentials: MD.
How much does Celeste Hart, MD prescribe under Medicare Part D? ▼
In 2023, Celeste Hart, MD wrote 1,612 Medicare Part D claims totaling $784K in drug costs for 298 beneficiaries.
What is Celeste Hart, MD's Medicare quality score? ▼
Celeste Hart, MD has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Celeste Hart, MD located? ▼
Celeste Hart, MD is located at 1705 S ADAMS ST, Tallahassee, FL, 32301. Phone: (850) 224-7154.
What is Celeste Hart, MD's NPI number? ▼
Celeste Hart, MD's National Provider Identifier (NPI) is 1932212263, issued on 08/17/2006.
Does Celeste Hart, MD prescribe more brand-name or generic drugs? ▼
Celeste Hart, MD's prescribing is 53% brand-name and 42% generic drugs by claim count, with $740K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Celeste Hart, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Celeste Hart, MD's most frequently prescribed drugs include Levothyroxine Sodium, Synthroid, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Celeste Hart, MD accept Medicare? ▼
Celeste Hart, MD appears in CMS Medicare data with 1,612 Part D claims and 298 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Celeste Hart, MD's credentials? ▼
Celeste Hart, MD's NPI is 1932212263 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.